The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Vaccines and multiple sclerosis: a systematic review
Abstract
Vaccinations are often the most effective tool against some disease known to mankind. This study offers a literature review on the role of vaccines regarding the risk of developing multiple sclerosis (MS) and MS relapse. The method used in this study is a systematic literature review on the database PubMed. The study found no change in risk of developing multiple sclerosis (MS) after vaccination against hepatitis B virus, human papillomavirus, seasonal influenza, measles-mumps-rubella, variola, tetanus, Bacillus Calmette-Guérin (BCG), polio, or diphtheria. No change in risk of relapse was found for influenza. Further research is needed for the potential therapeutic use of the BCG vaccine in patients in risk of developing MS and for the preventive potential of the tetanus and diphtheria vaccine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two recent systematic reviews looking at the association between different individual vaccines and central demyelinating disorders (hepatitis B, human papilloma virus (HPV), influenza, MMR, varicella, tetanus, Bacillus Calmette Guérin (BCG), polio or diphtheria) concluded that there was no relationship between receipt of a vaccine and development of MS (Mailand and Frederiksen, 2017; Mouchet et al”
From Vaccine Safety: Myths and Misinformation (2020) · cites this paper as Mailand and Frederiksen, 2017
In the citing paper
“Existing epidemiologic studies have found no associations between the number of different vaccines and an increased risk of autoimmune disorders.”
From Vaccine Safety: Myths and Misinformation (2020) · cites this paper as Mailand and Frederiksen, 2017
Citations
Cites
Vaccinations and the Risk of Relapse in Multiple Sclerosis
Confavreux, C., Suissa, S., Saddier, P., Bourdès, V., & Vukusic, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440501 · Cited by 490
Hepatitis B Vaccination and the Risk of Multiple Sclerosis
Ascherio, A., Zhang, S. M., Hernán, M. Á., Olek, M. J., COPLAN, P. M., Brodovicz, K. G., & Walker, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440502 · Cited by 433
Recombinant hepatitis B vaccine and the risk of multiple sclerosis
Hernán, M. Á., Jick, S. S., Olek, M. J., & Jick, H. (2004) · Neurology · doi:10.1212/01.wnl.0000138433.61870.82 · Cited by 302
Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults
Destefano, F. R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.504 · Cited by 256
Chao, C., Klein, N. P., Velicer, C. M., Sy, L. S., Slezak, J. M., Takhar, H. S., Ackerson, B. K., Cheetham, T. C., Hansen, J. R., Deosaransingh, K. A., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02467.x · Cited by 204
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
Langer-Gould, A. M., Qian, L., Tartof, S. Y., Brara, S. M., Jacobsen, S. J., Beaber, B., Sy, L. S., Chao, C., Hechter, R. C., & Tseng, H. F. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2633 · Cited by 190
Bardage, C., Persson, I., Örtqvist, Å., Bergman, U., Ludvigsson, J. F., & Granath, F. (2011) · BMJ · doi:10.1136/bmj.d5956 · Cited by 190
Scheller, N. M., Svanström, H., Pasternak, B., Arnheim‐Dahlström, L., Sundström, K., Fink, K., & Hviid, A. P. (2015) · JAMA · doi:10.1001/jama.2014.16946 · Cited by 182
Use of Bacille Calmette–Guerin (BCG) in multiple sclerosis
Ristori, G., Buzzi, M. G., Sabatini, U., Giugni, E., Bastianello, S., Viselli, F., Buttinelli, C., Ruggieri, S. A., Colonnese, C., Pozzilli, C., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1588 · Cited by 158
No increase in demyelinating diseases after hepatitis B vaccination
Zipp, F., Weil, J., & Einhäupl, K. M. (1999) · Nature Medicine · doi:10.1038/12376 · Cited by 156
Cited by
Sorted by citations
Items 101–154 of 154
Multiple Sklerose und Hepatitis-B-Impfung
Löbermann, M., Handorn, B., Winkelmann, A., Reisinger, E. C., Hartung, H., & Zettl, U. K. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0492-6 · Cited by 5
New Caledonian biology teachers’ opinions about vaccination: Preliminary findings
Frayon, S. (2020) · Health Education Journal · doi:10.1177/0017896919898738 · Cited by 5
Nervous System Infections and the Global Traveler
Reid, S., Thompson, H., & Thakur, K. T. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1649335 · Cited by 5
Ray, S. D., Luzum, J. A., Gray, J. P., & STOHS, S. J. (2021) · Side effects of drugs annual · doi:10.1016/s0378-6080(21)00054-4 · Cited by 5
Şahin (2024) · doi:10.1002/brb3.3587 · Cited by 5
Vaccination frequency in people newly diagnosed with multiple sclerosis
Darvishi, S., Donnachie, E., Gasperi, C., Hapfelmeier, A., & Hemmer, B. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231199084 · Cited by 4
Fneish, F., Frahm, N., Peters, M., Ellenberger, D., Haas, J., Löbermann, M., Pöhlau, D., Röper, A.-L., Schilling, S., Stahmann, A., et al. (2023) · Vaccines · doi:10.3390/vaccines11121859 · Cited by 5
Hughes, A. M., Ponsonby, A., Dear, K. B. G., Dwyer, T., Taylor, B. V., van der Mei, I. A. F., Valery, P. C., & Lucas, R. M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102062 · Cited by 4
Vaccination in B-cell–depleted patients with multiple sclerosis
Killestein, J., Pasquier, R. D., & Hemmer, B. (2020) · Neurology · doi:10.1212/wnl.0000000000010378 · Cited by 4
Electronic medical records in multiple sclerosis research
Damotte, V., & Gourraud, P. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12441 · Cited by 3
The Traveler With Preexisting Disease
McCarthy, A. E., & Burchard, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54696-6.00026-4 · Cited by 3
Solmaz, İ., & Anlar, B. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.06.002 · Cited by 3
Núñez, J. M., Ciuró, A. H., López‐López, L., Mateo, A. C., Hernández, S. H., Valenza-Peña, G., & Valenza, M. C. (2023) · Healthcare · doi:10.3390/healthcare11222925 · Cited by 7
Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians
Dyczkowska, K., & Kalinowska, A. (2023) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2023.0004 · Cited by 4
Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report
Ding, Y., Fu, T., Zhou, W., Zhang, X., Wang, R., & Liao, H. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2252252 · Cited by 3
Internal comorbidities and complications of multiple sclerosis therapy -don't be caught off guard!
Šťastná, D., Seňavová, J., Andělová, M., Menkyová, I., Pšenička, O., & Horáková, D. (2023) · Vnitřní lékařství · doi:10.36290/vnl.2023.058 · Cited by 3
Barboza, A. G., Sinay, V. J., Silva, B. A., Rojas, J. I., Ysrraelit, M. C., Contentti, E. C., Negrotto, L., Tavolini, D., Deri, N. H., Tizio, S., et al. (2020) · Neurología Argentina · doi:10.1016/j.neuarg.2020.09.002 · Cited by 2
Approaches to vaccine prevention in multiple sclerosis
Kasatkin, D. S., Korobko, D. S., Matson, M. D., Lendoeva, D. V., & Ivanova, S. P. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212209129 · Cited by 2
Vaccination in Individuals with Multiple Sclerosis – Part I
Çınar, B. P., Tuncer, A., Bilge, N., Bünül, S. D., Çelik, R. G. G., Dede, E. Ç., Genç, G., Karaman, B., Kılıç, A. K., Sarıteke, A., et al. (2023) · Turkish Journal Of Neurology · doi:10.4274/tnd.2023.62592 · Cited by 2
Monschein, T., Zrzavy, T., Löbermann, M., Winkelmann, A., Berger, T., Rommer, P. S., Hartung, H., & Zettl, U. K. (2021) · Der Nervenarzt · doi:10.1007/s00115-021-01154-5 · Cited by 2
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?
Bianco, A. D., Sante, G. D., Colò, F., Arcangelis, V. D., Cicia, A., Giacomo, P. D., Bonis, M. D., Morganti, T., Carlomagno, V., Lucchini, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084556 · Cited by 1
Asada, S., Odera, H., Morishita, K., & Mori, S. (2025) · Cureus · doi:10.7759/cureus.83454 · Cited by 1
Podlecka‐Piętowska, A., Sierdziński, J., Nojszewska, M., Stawicki, J., Bartosik-Psujek, H., Lech, B., Popiel, M., Perenc, A., Kułakowska, A., Czarnowska, A., et al. (2024) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.96425 · Cited by 1
mRNA Vaccination for Induction of Immune Tolerance Against Autoimmune Disease
Gissler, M. C., Picard, F. S. R., Marchini, T., Winkels, H., & Wolf, D. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch7 · Cited by 1
Risikomanagement und alltagspraktische Aspekte
Aktaş, O., & Zipp, F. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-22084-5.00020-2
Do Vaccines Cause Multiple Sclerosis (MS)?
Dudley, M. Z., Salmon, D. A., Halsey, N. A., Orenstein, W. A., Limaye, R. J., O’Leary, S. T., & Omer, S. B. (2018) · Springer eBooks · doi:10.1007/978-3-319-94694-8_43
Yeh, E. A., & Graves, J. S. (2019) · Neurology · doi:10.1212/wnl.0000000000008000
Unterm Strich nützt Impfen auch bei den meisten Immunsupprimierten
Stoll, M. (2019) · Pneumo News · doi:10.1007/s15033-019-1248-0
Impfen erhöht nicht das Risiko für Multiple Sklerose
Nelles, G. (2019) · NeuroTransmitter · doi:10.1007/s15016-019-6914-2
Impfungen gegen Infektionskrankheiten bei Multipler Sklerose
Zettl, U. K. (2020) · Nervenheilkunde · doi:10.1055/a-1059-1895
Coronavirus and Multiple Sclerosis, Autopsy and Biopsy and Choice of Therapy
Roshanisefat, H. (2020) · Acta Scientific Medical Sciences · doi:10.31080/asms.2020.04.0705
Nečas, J., & Nečas, T. (2020) · Pediatrie pro praxi · doi:10.36290/ped.2020.050
Features of the course of influenza in some categories of neurological patients
Demianovskaya, E. G., & Vasiliev, A. S. (2021) · Лечащий врач · doi:10.51793/os.2021.24.3.011
Löbermann, M., Handorn, B., Winkelmann, A., Reisinger, E. C., Hartung, H., & Zettl, U. K. (2018) · Der Nervenarzt
Should Your Baby Be Vaccinated?
Kramer, M. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-74765-7_11
(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-22085-2.00028-8
(2020) · International Journal of MS Care · doi:10.7224/1537-2073-22.2.90
Management of secondary-progressive multiple sclerosis
Elišák, M. (2022) · Neurologie pro praxi · doi:10.36290/neu.2021.054
Kizek, Ö., Yalçın, G. Y., Gündüz, T., Kürtüncü, M., & Eraksoy, M. (2022) · Turkish Journal Of Neurology · doi:10.4274/tnd.2022.97493
Non-specific Effects of Vaccines
Pittet, L. F., Netea, M. G., & Curtis, N. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00003-7
Different HLA genotype pattern in patients with Multiple Sclerosis onset after COVID-19 vaccine.Preprint
Bianco, A. D., Sante, G. D., Colò, F., Arcangelis, V. D., Cicia, A., Giacomo, P. D., Bonis, M. D., Morganti, T., Carlomagno, V., Lucchini, M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3470613/v1
Take Your Shots? Parents’ Fear of Adverse Effects of Vaccines
Kramer, M. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-46022-7_21
Lyou, H. J., & Lee, H. L. (2023) · Journal of Multiple Sclerosis and Neuroimmunology · doi:10.59578/jmsni.14.2.73
BCG vaccination and multiple sclerosis risk: A Norwegian cohort study
Nakken, O., Aarseth, J. H., Wergeland, S., Stigum, H., Meyer, H. E., & Holmøy, T. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241230440
Galitskaya, M. G., Abdullaeva, L. М., Makarova, S. G., & Fisenko, А. P. (2024) · Russian Pediatric Journal · doi:10.46563/1560-9561-2024-27-3-205-211
Mohamed, S. A. A., Elkarim, M. A., & Al-Jaberi, S. A. (2024) · Cureus · doi:10.7759/cureus.75889
Akhtar, S., El-Muzaini, H., Al-Hashel, J. Y., & Alroughani, R. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08187-7
Neurologic Complications of Immunization
Chiriboga, C. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00136-0
Primum non nocere: How safe is modern therapy for multiple sclerosis?
Šťastná, D., & Horáková, D. (2025) · Klinická farmakologie a farmacie · doi:10.36290/far.2025.036
Mouchet, J. (2019) · theses.fr (ABES) · doi:10.70675/84942651z2b7az472dz97b2z9963b18ee960
Is There a Relationship Between Vaccines and Autoimmunity, Allergies, and Asthma?
Equils, O., O’Connell, P., & Narla, S. (2026) · Springer eBooks · doi:10.1007/978-1-0716-5464-4_16
Barhoum, B., Hecker, M., Suntah, A. M., Langenberger, J. E., Baldt, J., Streckenbach, B., Richter, J., Frahm, N., Heidler, F., & Zettl, U. K. (2026) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864261476877
Howard, J. (2026) · Springer eBooks · doi:10.1007/978-3-032-39494-1_6
Metadata
- Authors
- Mailand, M. T., & Frederiksen, J. L.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Frederiksen, Jette Lautrup
- Venue
- Journal of Neurology
- Published
- 2016-09-07
- Volume
- 264
- Issue
- 6
- Pages
- 1035-1050
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W2514636267
- Cited by
- 154
- References
- 63
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 14 · 2023: 23 · 2022: 20 · 2021: 32 · 2020: 22 · 2019: 12 · 2018: 14 · 2017: 6 · 2016: 1
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- multiple sclerosis, vaccines, hepatitis B vaccine, HPV vaccine, seasonal influenza vaccine, MMR vaccine, smallpox vaccine, tetanus vaccine, BCG vaccine, diphtheria vaccine, polio vaccine, multiple sclerosis risk, relapse
- MeSH terms
- Animals, Humans, Multiple Sclerosis, Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review